MX2020005942A - Delgada pelicula oral con alta carga de agente activo. - Google Patents

Delgada pelicula oral con alta carga de agente activo.

Info

Publication number
MX2020005942A
MX2020005942A MX2020005942A MX2020005942A MX2020005942A MX 2020005942 A MX2020005942 A MX 2020005942A MX 2020005942 A MX2020005942 A MX 2020005942A MX 2020005942 A MX2020005942 A MX 2020005942A MX 2020005942 A MX2020005942 A MX 2020005942A
Authority
MX
Mexico
Prior art keywords
active agent
high load
oral film
oral
thin oral
Prior art date
Application number
MX2020005942A
Other languages
English (en)
Inventor
Markus Müller
Christoph Schmitz
Marius Bauer
Michael Linn
Original Assignee
Lts Lohmann Therapie Systeme Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lts Lohmann Therapie Systeme Ag filed Critical Lts Lohmann Therapie Systeme Ag
Publication of MX2020005942A publication Critical patent/MX2020005942A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/006—Oral mucosa, e.g. mucoadhesive forms, sublingual droplets; Buccal patches or films; Buccal sprays
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A61K47/38—Cellulose; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7007—Drug-containing films, membranes or sheets
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Nutrition Science (AREA)
  • Physiology (AREA)
  • Inorganic Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pain & Pain Management (AREA)
  • Psychiatry (AREA)
  • Zoology (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

La presente invención se refiere a una delgada película oral que comprende por lo menos un derivado de celulosa y, por lo menos un agente farmacéuticamente activo que tiene una solubilidad en agua de, a lo más 50 g/L a 20 °C y un pH de 6 a 7 y que está contenido en la delgada película oral en una cantidad de por lo menos 20 % en peso con relación al peso total de la delgada película oral y a un método para la producción de dicha delgada película oral y su uso como un medicamento.
MX2020005942A 2017-12-06 2018-12-06 Delgada pelicula oral con alta carga de agente activo. MX2020005942A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE102017129012.5A DE102017129012A1 (de) 2017-12-06 2017-12-06 Oraler Dünnfilm mit hoher Wirkstoffbeladung
PCT/EP2018/083781 WO2019110727A1 (de) 2017-12-06 2018-12-06 Oraler Dünnfilm mit hoher Wirkstoffbeladung

Publications (1)

Publication Number Publication Date
MX2020005942A true MX2020005942A (es) 2020-08-24

Family

ID=64746523

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2020005942A MX2020005942A (es) 2017-12-06 2018-12-06 Delgada pelicula oral con alta carga de agente activo.

Country Status (11)

Country Link
US (1) US12527751B2 (es)
EP (1) EP3720419A1 (es)
JP (1) JP7444775B2 (es)
KR (1) KR102378847B1 (es)
CN (1) CN111447920A (es)
AU (1) AU2018380864B2 (es)
CA (1) CA3085020C (es)
DE (1) DE102017129012A1 (es)
MX (1) MX2020005942A (es)
RU (1) RU2754824C1 (es)
WO (1) WO2019110727A1 (es)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PL3505157T3 (pl) 2017-12-29 2022-04-11 Celon Pharma S.A. Kompozycja ketaminy w postaci suchego proszku do podawania dopłucnego w leczeniu depresji opornej na leczenie
DE102019117870B3 (de) * 2019-07-02 2020-11-26 Lts Lohmann Therapie-Systeme Ag Oraler Dünnfilm
DE102019135432A1 (de) * 2019-12-20 2021-06-24 Lts Lohmann Therapie-Systeme Ag Lösliche Rückschicht für OTF
EP4157244A4 (en) * 2020-06-02 2024-07-17 IX Biopharma Limited METHODS OF TREATING MAJOR DEPRESSIVE DISORDER AND TREATMENT-RESISTANT DEPRESSION
GB2596592A (en) * 2020-07-03 2022-01-05 Alkaloid Ad Skopje Pharmaceutical formulation
JP2023548215A (ja) * 2020-11-09 2023-11-15 エルテーエス ローマン テラピー－ジステーメ アーゲー 経口薄フィルム
DE102021120937A1 (de) * 2021-08-11 2023-02-16 Lts Lohmann Therapie-Systeme Ag. Oraler Dünnfilm
DE102021100752A1 (de) * 2021-01-15 2022-07-21 Lts Lohmann Therapie-Systeme Ag. Oraler Dünnfilm
DE102021105268A1 (de) * 2021-03-04 2022-09-08 Lts Lohmann Therapie-Systeme Ag. Oraler Dünnfilm
DE102021130950A1 (de) * 2021-11-25 2023-05-25 Lts Lohmann Therapie-Systeme Ag. Applikationshilfe
DE102021130954A1 (de) * 2021-11-25 2023-05-25 Lts Lohmann Therapie-Systeme Ag. Orales Micronadel Patch
JP7847233B2 (ja) 2022-04-26 2026-04-16 イーチャン・ヒューマンウェル・ファーマシューティカル・カンパニー・リミテッド エスケタミン液体製剤及びその使用
EP4480473A4 (en) 2022-04-26 2025-06-04 Yichang Humanwell Pharmaceutical Co., Ltd. LIQUID ESKETAMINE PREPARATION AND USE THEREOF
CN118986868A (zh) * 2023-05-19 2024-11-22 宜昌人福药业有限责任公司 氯胺酮液体制剂及其用途

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN103596551B (zh) * 2011-06-08 2017-02-22 Lts勒曼治疗系统股份公司 含有用于掩味的离子交换树脂的食用口服条或糯米纸囊剂型
WO2014020155A1 (en) * 2012-08-02 2014-02-06 Clinpharm Reform Gmbh Oral transmucosal adminstration forms of s-ketamine
US10413516B2 (en) * 2013-05-09 2019-09-17 Cure Pharmaceutical Corporation Thin film with high load of active ingredient
US11207316B2 (en) * 2014-05-30 2021-12-28 West Virginia University Ketamine or dextromethorphan formulations and methods of use
JP6827923B2 (ja) 2014-11-04 2021-02-10 アキュコート エービー デキサメタゾン口腔内フィルム
CN105997955B (zh) * 2016-06-28 2017-09-12 力品药业（厦门）有限公司 一种帕洛诺司琼口腔膜剂及其制备方法
DE102017112527B4 (de) * 2017-06-07 2019-01-03 Lts Lohmann Therapie-Systeme Ag Schnell zerfallende Schaumwafer mit hohem Flächengewicht

Also Published As

Publication number Publication date
EP3720419A1 (de) 2020-10-14
CN111447920A (zh) 2020-07-24
JP7444775B2 (ja) 2024-03-06
JP2021516212A (ja) 2021-07-01
US12527751B2 (en) 2026-01-20
CA3085020C (en) 2023-01-17
KR20200096804A (ko) 2020-08-13
KR102378847B1 (ko) 2022-03-24
BR112020010175A2 (pt) 2020-11-03
AU2018380864A1 (en) 2020-06-11
AU2018380864B2 (en) 2021-10-07
DE102017129012A1 (de) 2019-06-06
WO2019110727A1 (de) 2019-06-13
US20200383936A1 (en) 2020-12-10
CA3085020A1 (en) 2019-06-13
RU2754824C1 (ru) 2021-09-07

Similar Documents

Publication Publication Date Title
AR115939A2 (es) Composición que contiene palmitoil-etanolamida ultra-micronizada
CL2017001488A1 (es) Benzamidas sustituidas con 1,3–tiazol–2–ilo
AR098168A1 (es) Formulación estable de insulina glulisina
BR112018075140A2 (pt) composição na forma de uma solução aquosa injetável, e, formulação de dose única a um ph de 7 a 7,8
MX390954B (es) Composiciones que comprenden una combinacion de un anticuerpo anti muerte programada 1 (pd-1) y otro anticuerpo.
ES2543957T3 (es) Nueva composición farmacéutica para el tratamiento de infecciones fúngicas
CL2017000240A1 (es) Compuestos activos hacia bromodominios
BR112013000537A2 (pt) composição aquosa contendo bromexina
TR201904455T4 (tr) Nükleer taşıma modülatörleri olarak 1,2,4-triazoller ve bunların kullanımları.
MX2020005841A (es) Derivados de 1,2,4-oxadiazol como inhibidores de histona-desacetilasa 6.
EP3695830A4 (en) USE OF A COMPOSITION WITH EXOSOMES FROM STEM CELLS AS AN ACTIVE INGREDIENT FOR STRENGTHENING AND FUNCTIONAL IMPROVEMENT OF THE SKIN BARRIER
UY35276A (es) Nuevos compuestos que inhiben la actividad de Lp-PLA2
CR20160433A (es) Nuevos compuestos
DOP2016000007A (es) Pirazolpiridinas sustituidas
ECSP20023626A (es) Novedosos derivados de pirazolo-pirrolo-pirimidina como inhibidores de p2x3
MX2016015437A (es) Combinacion que comprende un glucocorticoide y edo-s101.
CL2015002466A1 (es) Formulaciones de compuestos orgánicos
DOP2016000118A (es) Tienopirimidinas como inhibidores mknk1 y mknk2
CL2016000019A1 (es) Compuestos derivados de dihidroxifenilo deuterado o una sal de los mismos; composición farmacéutica que los comprende y su uso para el tratamiento de trastornos mediados por neurotransmisores tales como hipotensión, trastornos del sueño, enfermedad de alzheimer y depresión.
UA110979C2 (uk) Рідка фармацевтична композиція, яка включає нітизинон
ECSP17005294A (es) Composición adhesiva
CL2012003265A1 (es) Polisacarido de semillas de tamarindo para usarse en el tratamiento de enfermedades infecciosas; composicion farmacéutica y/o dermocosmética antiinflamatoria que contiene dicho polisacárido; uso de un polisacárido de semilla de tamarindo.
DOP2016000251A (es) Inhibidores de las vías de señalización de wnt
AR089114A1 (es) PREVENCION DE LOS EFECTOS ADVERSOS CAUSADOS POR LOS ANTICUERPOS BIESPECIFICOS EpCAMxCD3
BR112016009214A8 (pt) uso de um composto para preparação de um medicamento para o tratamento de distrofia muscular e composição farmacêutica